Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.

Viruses - 6 Jul 2020

Choga Wonderful Tatenda, Anderson Motswedi, Zumbika Edward, Phinius Bonolo B, Mbangiwa Tshepiso, Bhebhe Lynnette N, Baruti Kabo, Kimathi Peter Opiyo, Seatla Kaelo K, Musonda Rosemary M, Bell Trevor Graham, Moyo Sikhulile, Blackard Jason T, Gaseitsiwe Simani

Abstract excerpt

Hepatitis B virus (HBV) is the primary cause of liver-related malignancies worldwide, and there is no effective cure for chronic HBV infection (CHB) currently. Strong immunological responses induced by T cells are associated with HBV clearance during acute infection; however, the repertoire of epitopes (epi) presented by major histocompatibility complexes (MHCs) to elicit these responses in various African...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Botswana
Share to Epitopes, T-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class II

Share to Hepatitis B

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to HLA Antigens

Share to Leukocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 32640609
DOI: 10.3390/v12070731
PMCID: PMC7412261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.PMID 32640609Read ↗

Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.Semantic proximity Read ↗

Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.Semantic proximity Read ↗

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approachSemantic proximity Read ↗

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana.Semantic proximity Read ↗

Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.Semantic proximity Read ↗

Prediction of T-cell epitopes of hepatitis C virus genotype 5a.Semantic proximity Read ↗

Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations.Semantic proximity Read ↗

Prevalence of Hepatitis B Virus Mutations Associated with Hepatocellular Carcinoma in HBV and HIV Co-infected Adults in BotswanaSemantic proximity Read ↗

Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues.Semantic proximity Read ↗

A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics.Semantic proximity Read ↗

In silico design of novel recombinant antigens containing immunologically relevant regions of wild-type and escape mutant variants of HBsAg.Semantic proximity Read ↗

Computational Prioritization of T Cell Epitopes to Overcome HLA Restriction and Antigenic Diversity in <i>Plasmodium falciparum</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.